Literature DB >> 4588939

[Depressive effects of physostigmine].

J Modestin, J Hunger, R B Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4588939     DOI： 10.1007/bf00347089

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


× No keyword cloud information.
  11 in total

1.  SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINESTERASE ADMINISTRATION.

Authors:  M B BOWERS; E GOODMAN; V M SIM
Journal:  J Nerv Ment Dis       Date:  1964-04       Impact factor: 2.254

2.  Clinical quantification of depressive reactions.

Authors:  R P CUTLER; H D KURLAND
Journal:  Arch Gen Psychiatry       Date:  1961-09

3.  Psychiatric sequelae of chronic exposure to organophosphorus insecticides.

Authors:  S GERSHON; F H SHAW
Journal:  Lancet       Date:  1961-06-24       Impact factor: 79.321

4.  The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis.

Authors:  D W ROWNTREE; S NEVIN; A WILSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1950-02       Impact factor: 10.154

5.  [Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)].

Authors:  J Modestin; R B Schwartz; J Hunger
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1973-11

6.  Cholinergic reversal of manic symptoms.

Authors:  B J Carroll; A Frazer; A Schless; J Mendels
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

7.  A cholinergic-adrenergic hypothesis of mania and depression.

Authors:  D S Janowsky; M K el-Yousef; J M Davis; H J Sekerke
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

8.  [A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies].

Authors:  D von Zerssen; D M Koeller; E R Rey
Journal:  Arzneimittelforschung       Date:  1970-07

9.  Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate).

Authors:  D GROB; J C HARVEY
Journal:  J Clin Invest       Date:  1958-03       Impact factor: 14.808

10.  The administration of di-isopropyl fluorophosphate (DFP) to man.

Authors:  D GROB; J L LILIENTHAL
Journal:  Bull Johns Hopkins Hosp       Date:  1947-10
View more
  8 in total

Review 1.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

2.  The effects of lithium and physostigmine on rat brain acetylcholinesterase activity.

Authors:  L L Simpson
Journal:  Psychopharmacologia       Date:  1974

3.  The effects of alaproclate on the pupillary responses to tyramine, phenylephrine and pilocarpine in depressed patients.

Authors:  C Thompson; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

5.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

6.  Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells.

Authors:  H W Moises; B Bering; W E Müller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

7.  Clinical investigations into antidepressive mechanisms. I. Antihistaminic and cholinolytic effects: amitriptyline versus promethazine.

Authors:  H Beckmann; M Schmauss
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

8.  Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex.

Authors:  Leila Nabulsi; Jennifer Farrell; Genevieve McPhilemy; Liam Kilmartin; Maria R Dauvermann; Theophilus N Akudjedu; Pablo Najt; Srinath Ambati; Fiona M Martyn; James McLoughlin; Michael Gill; James Meaney; Derek Morris; Thomas Frodl; Colm McDonald; Brian Hallahan; Dara M Cannon
Journal:  Neuropsychopharmacology       Date:  2022-01-19       Impact factor: 8.294
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.